PADCEVTM (enfortumab vedotin) in Combination with pembrolizumab is Now Available for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy in India
First regimen to be approved in India to demonstrate superiority to platinum-containing chemotherapy, the current standard of care for adult patients with unresectable or metastatic urothelial cancer for nearly 40…

